Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: FISH testimony - message from investorshub side

These pages relate to Mr. Fish’s unsupported allegations that Mac Leckrone wanted Mr. Fish to change his testimony.


But in the designations HTC disclosed yesterday, HTC altered its initial designation. Instead of the unbroken range (26:9-28:14), HTC split the designated testimony in to three separate ranges: 26:9-27:8, 28:2-28:9, and 28:12-14. Why? To eliminate from the Jury’s consideration Mr. Fish’s testimony that he never had any interaction with Mac Leckrone. HTC removed the following testimony from its designations:

Q. When did Mac Leckrone visit you?

A. I believe it was three days ago.


MR. MELITO: Objection to -- object to form. It's ambiguous because they did not meet.


A. That's correct. We did not meet.


Q. (By Mr. Walker) How did Mr. Leckrone -- how did Mac Leckrone contact you?

A. I arrived at my attorney's office for a purported conference call and noticed Mr. Leckrone was on the sign-in sheet.

Q. And did -- did you have a conversation with Mr. Leckrone?
A. No.
Q. Did you meet with Mr. Leckrone?
A. No.
Q. Did you receive any written communication from Mr. Leckrone?
A. No. R. Fish

Depo, 12/17/2010, 27:9-28:1.

Share
New Message
Please login to post a reply